Immunological and genetic aspects of asthma and allergy

Journal of Asthma and Allergy

Volumn 3, Issue , 2010, Pages 107-121

  Madore, Anne Marie ^a   Laprise, Catherine ^a  

^a UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

Author keywords

Allergy; Asthma; Genetics; Genomics; Immune response

Indexed keywords

EID: 85016317282     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S8970     Document Type: Review

References (160)

1. Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC. Immunologic principles of allergic disease. J Dtsch Dermatol Ges. 2007;5(11): 1015-1028.
2. Platts-Mills TAE. Immediate hypersensitivity (Type I). In: Male D, Brostoff J, Roth DB, Roitt I, editors. Immunology. 7th ed. Philadelphia, PA: Elsevier; 2006:423-447.
3. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377-383.
4. Lack G. New developments in food allergy: old questions remain. J Allergy Clin Immunol. 2004;114(1):127-130.
5. Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. Developed for the Global Initiative for Asthma. Medical Research Institute of New Zealand, Wellington, New Zealand and University of Southampton, Southampton, United Kingdom; 2004.
6. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23-34.
7. Gell PGH, Coombs RRA. The classification of allergic reactions underlying disease. In: Coombs RRA, Gell PGH, editors. Clinical Aspects of Immunology. London, UK: Blackwell Science; 1963.
8. Verstraelen S, Bloemen K, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol In Vitro. 2008;22(6):1419-1431.
9. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 2006;6(3):218-230.
10. Metzger H. The receptor with high affinity for IgE. Immunol Rev. 1992;125:37-48.
11. Male D. Hypersensitivity (Type II). In: Male D, Brostoff J, Roth DB, Roitt I, editors. Immunology. 7th ed. Philadelphia, PA: Elsevier; 2006: 449-460.
12. Hay F, Westwood OMR. Hypersensitivity (Type III). In: Male D, Brostoff J, Roth DB, Roitt I, editors. Immunology. 7th ed. Philadelphia: Elsevier; 2006:461-476.
13. Britton W. Type IV hypersensitivity. In: Male D, Brostoff J, Roth DB, Roitt I, editors. Immunology. 7th ed. Philadelphia, PA: Elsevier; 2006: 477-491.
14. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56(9):813-824.
15. Hopp RJ, Bewtra AK, Watt GD, Nair NM, Townley RG. Genetic analysis of allergic disease in twins. J Allergy Clin Immunol. 1984; 73(2):265-270.
16. Lichtenstein P, Svartengren M. Genes, environments, and sex: factors of importance in atopic diseases in 7-9-year-old Swedish twins. Allergy. 1997;52(11):1079-1086.
17. Isidoro-Garcia M, Davila-Gonzalez I, Pascual de Pedro M, Sanz-Lozano C, Lorente-Toledano F. Interactions between genes and the environment. Epigenetics in allergy. Allergol Immunopathol (Madr). 2007;35(6):254-258.
18. Gartner K. A third component causing random variability beside environment and genotype. A reason for the limited success of a 30 year long effort to standardize laboratory animals? Lab Anim. 1990; 24(1):71-77.
19. Hong X, Tsai HJ, Wang X. Genetics of food allergy. Curr Opin Pediatr. 2009;21(6):770-776.
20. Renkonen J, Mattila P, Parviainen V, Joenvaara S, Toppila-Salmi S, Renkonen R. A network analysis of the single nucleotide polymorphisms in acute allergic diseases. Allergy. 2010;65(1):40-47.
21. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125(1):16-29, e1-e11; quiz 30-31.
22. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006;7(2):95-100.
23. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103(1 Pt 1):125-138.
24. Zhang J, Pare PD, Sandford AJ. Recent advances in asthma genetics. Respir Res. 2008;9:4.
25. Palikhe NS, Kim SH, Park HS. What do we know about the genetics of aspirin intolerance? J Clin Pharm Ther. 2008;33(5):465-472.
26. Gueant JL, Gueant-Rodriguez RM, Gastin IA, et al. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Curr Pharm Des. 2008;14(27):2770-2777.
27. Castro-Giner F, Bustamante M, Ramon Gonzalez J, et al. A poolingbased genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). BMC Med Genet. 2009;10:128.
28. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5(4):309-316.
29. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6): 872-897.
30. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2008.
31. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2006.
32. Humbert M. Does “intrinsic” asthma exist? Rev Mal Respir. 2000; 17(1 Pt 2):245-254.
33. Kerkhof M, De Graaf A, Droste JHJ. Prevalentie van astmatische klachten in drie regio’s in Nederland. Tijdschr Soc Gezondheidsz. 1994;72:181-185.
34. Platts-Mills TA, Carter MC. Asthma and indoor exposure to allergens. N Engl J Med. 1997;336(19):1382-1384.
35. Rijcken B, Kerkhof M, de Graaf A. Europees Luchtweg Onderzoek Nederland (ELON). Groningen: Rijksuniversiteit Groningen; 1996.
36. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). Ann Allergy. 1991;67(2 Pt 1):147-154.
37. Woolcock AJ, Peat JK, Salome CM, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987;42(5):361-368.
38. Kiley J, Smith R, Noel P. Asthma phenotypes. Curr Opin Pulm Med. 2007;13(1):19-23.
39. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804-813.
40. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol. 1992;89(1 Pt 1): 23-30.
41. Postma DS, Koppelman GH, Meyers DA. The genetics of atopy and airway hyperresponsiveness. Am J Respir Crit Care Med. 2000; 162(3 Pt 2):S118-S123.
42. Male D, Brostoff J, Roth D, Roitt I. Immunology. 7th ed. London: Mosby; 2006.
43. Beasley R, Pekkanen J, Pearce N. Has the role of atopy in the development of asthma been over-emphasized? Pediatr Pulmonol Suppl. 2001;23:149-150.
44. Kay AB. The role of eosinophils in the pathogenesis of asthma. Trends Mol Med. 2005;11(4):148-152.
45. Constant SL, Brogdon JL, Piggott DA, et al. Resident lung antigenpresenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest. 2002;110(10):1441-1448.
46. Julia V, Hessel EM, Malherbe L, Glaichenhaus N, O’Garra A, Coffman RL. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity. 2002;16(2):271-283.
47. Riese RJ, Chapman HA. Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol. 2000;12(1): 107-113.
48. Kuipers H, Heirman C, Hijdra D, et al. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. J Leukoc Biol. 2004;76(5):1028-1038.
49. Anderson GP. The immunobiology of early asthma. Med J Aust. 2002; 177 Suppl:S47-S49.
50. Dahlen B, Shute J, Howarth P. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax. 1999;54(7):590-596.
51. Kaur D, Saunders R, Berger P, et al. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med. 2006;174(11): 1179-1188.
52. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117(6): 1277-1284.
53. Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol. 2003;111(6):1345-1352.
54. Holsapple MP, Jones D, Kawabata TT, et al. Assessing the potential to induce respiratory hypersensitivity. Toxicol Sci. 2006; 91(1):4-13.
55. Ogawa Y, Calhoun WJ. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol. 2006;118(4):789-798; quiz 799-800.
56. Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol. 1999;31(2):119-133.
57. Nouri-Aria KT, Irani AM, Jacobson MR, et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol. 2001;108(2):205-211.
58. Nissim Ben Efraim AH, Levi-Schaffer F. Tissue remodeling and angiogenesis in asthma: the role of the eosinophil. Ther Adv Respir Dis. 2008;2(3):163-171.
59. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy. 2004;59(8):793-805.
60. Lee JJ, Dimina D, Macias MP, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 2004;305(5691): 1773-1776.
61. Schmid-Grendelmeier P, Altznauer F, Fischer B, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol. 2002;169(2):1021-1027.
62. Adelroth E, Morris MM, Hargreave FE, O’Byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med. 1986;315(8):480-484.
63. Lee E, Robertson T, Smith J, Kilfeather S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med. 2000;161(6): 1881-1886.
64. Marom Z, Shelhamer JH, Bach MK, Morton DR, Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis. 1982; 126(3):449-451.
65. Frigas E, Motojima S, Gleich GJ. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J Suppl. 1991;13:123s-135s.
66. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol. 2007;119(6):1313-1320.
67. Van Hove CL, Maes T, Joos GF, Tournoy KG. Chronic inflammation in asthma: a contest of persistence vs resolution. Allergy. 2008;63(9):1095-1109.
68. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346(22):1699-1705.
69. Plante S, Semlali A, Joubert P, et al. Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio. J Allergy Clin Immunol. 2006;117(6):1321-1327.
70. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002;82(1):97-130.
71. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258-2261.
72. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113(4):551-560.
73. Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305(5691):1776-1779.
74. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol. 2006;118(5):1082-1089.
75. Ordonez CL, Khashayar R, Wong HH, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 2001;163(2): 517-523.
76. Perez-Vilar J. Mucin granule intraluminal organization. Am J Respir Cell Mol Biol. 2007;36(2):183-190.
77. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest. 2006;129(4):1068-1087.
78. Smit JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol. 2006;533(1-3):277-288.
79. Johnson SR, Knox AJ. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol Sci. 1997;18(8):288-292.
80. Panettieri RA Jr. Airway smooth muscle: an immunomodulatory cell. J Allergy Clin Immunol. 2002;110 Suppl 6:S269-S274.
81. Bosse Y, Pare PD, Seow CY. Airway wall remodeling in asthma: from the epithelial layer to the adventitia. Curr Allergy Asthma Rep. 2008; 8(4):357-366.
82. Dube J, Chakir J, Laviolette M, et al. In vitro procollagen synthesis and proliferative phenotype of bronchial fibroblasts from normal and asthmatic subjects. Lab Invest. 1998;78(3):297-307.
83. Carlsen KH, Kowalski ML. Asthma, allergy, the athlete and the Olympics. Allergy. 2008;63(4):383-386.
84. Humbert M, Menz G, Ying S, et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences.Immunol Today. 1999;20(11):528-533.
85. Corrigan C. Mechanisms of intrinsic asthma. Curr Opin Allergy Clin Immunol. 2004;4(1):53-56.
86. Jayaratnam A, Corrigan C., Lee TH. The continuing enigma of non-atopic asthma. Clin Exp Allergy. 2005;35(7):835-837.
87. Humbert M, Grant JA, Taborda-Barata L, et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996;153(6 Pt 1): 1931-1937.
88. Ying S, Humbert M, Meng Q, et al. Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol. 2001;107(4):686-692.
89. Ying S, Meng Q, Zeibecoglou K, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol. 1999;163(11):6321-6329.
90. Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med. 1996;154(5): 1497-1504.
91. Ying S, Humbert M, Barkans J, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1997;158(7):3539-3544.
92. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol. 2006;533(1-3):145-155.
93. Kim SH, Park HS. Pathogenesis of nonsteroidal antiinflammatory druginduced asthma. Curr Opin Allergy Clin Immunol. 2006;6(1):17-22.
94. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117(3):522-543.
95. Dykewicz MS. Occupational asthma: current concepts in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2009;123(3):519-528; quiz 529-530.
96. Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167(5):787-797.
97. Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008;134 Suppl 3:1S-41S.
98. Lecomte J. Asthma and exercise. Rev Med Brux. 2002;23(4): A206-A210.
99. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39(9): 1487-1492.
100. Weiler JM, Bonini S, Coifman R, et al. American Academy of Allergy, Asthma and Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119(6):1349-1358.
101. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is… J Allergy Clin Immunol. 2000;106(3):453-459.
102. Anderson SD. Is there a unifying hypothesis for exercise-induced asthma? J Allergy Clin Immunol. 1984;73(5 Pt 2):660-665.
103. McFadden ER Jr. Hypothesis: exercise-induced asthma as a vascular phenomenon. Lancet. 1990;335(8694):880-883.
104. Buist AS. Definitions. In: Barnes PJ, Drazen JM, Rennard SI, Thomson NC, editors. Asthma and COPD. 2nd ed. San Diego, CA: Academic Press, Elsevier; 2009:3-7.
105. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med. 1999;159(1):228-234.
106. Hamzaoui A, Chaouch N, Grairi H, Ammar J, Hamzaoui K. Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients. Mediators Inflamm. 2005;2005(3):160-166.
107. O’Sullivan SM. Asthma death, CD8+ T cells, and viruses. Proc Am Thorac Soc. 2005;2(2):162-165.
108. Truyen E, Coteur L, Dilissen E, et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax. 2006;61(3):202-208.
109. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35.
110. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med. 1993; 177(2):397-407.
111. MacLean JA, Xia W, Pinto CE, Zhao L, Liu HW, Kradin RL. Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity. Am J Pathol. 1996;148(2):657-666.
112. Bissonnette E. Alveolar macrophages in the pathogenesis of asthma. Recent Res Devol Allergy Clin Immunol. 2000;1:129-141.
113. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol. 2004;31(1):3-7.
114. Cooke RA, van der Veer AJ. Human sensitization. J Immunol. 1916;1: 201-305.
115. Drinkwater H. Mendelian hereditary in asthma. Br Med J. 1909;1:88.
116. Los H, Postmus PE, Boomsma DI. Asthma genetics and intermediate phenotypes: a review from twin studies. Twin Res. 2001;4(2): 81-93.
117. Rackemann FM. Studies in asthma. II. An analysis of two hundred and thirteen cases in which the patients were relieved for more than two years. Arch Intern Med. 1928;41:346-369.
118. Schwartz M. Heredity in bronchial asthma; a clinical and genetic study of 191 asthma probands and 50 probands with Baker’s asthma. Acta Allergol Suppl (Copenh). 1952;2:1-288.
119. Spain WC, Cooke RA. Studies in specific hypersensitiveness. XI. The familial occurrence of hayfever and bronchial asthma. J Immunol. 1924;9:521-569.
120. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med. 2008; 177(6): 567-573.
121. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol. 2008;8(3):169-182.
122. Barnes PJ. New drugs for asthma. Nat Rev Drug Discov. 2004;3(10): 831-844.
123. Kazani S, Wechsler ME, Israel E. The role of pharmacogenomics in improving the management of asthma. J Allergy Clin Immunol. 125(2):295-302; quiz 303-304.
124. Koppelman GH, te Meerman GJ, Postma DS. Genetic testing for asthma. Eur Respir J. 2008;32(3):775-782.
125. Moffatt MF. Genes in asthma: new genes and new ways. Curr Opin Allergy Clin Immunol. 2008;8(5):411-417.
126. Madore AM, Perron S, Turmel V, Laviolette M, Bissonnette E., Laprise C. Alveolar macrophages in allergic asthma: an expression signature characterized by heat shock protein pathways. Hum Immunol. 2010;71(2):144-150.
127. Zhu M, Zhao S. Candidate gene identification approach: progress and challenges. Int J Biol Sci. 2007;3(7):420-427.
128. Izuhara K, Saito H. Microarray-based identification of novel biomarkers in asthma. Allergol Int. 2006;55(4):361-367.
129. Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics. 2004;5(1):21.
130. Willis-Owen SA, Cookson WO, Moffatt MF. Genome-wide association studies in the genetics of asthma. Curr Allergy Asthma Rep. 2009;9(1):3-9.
131. Griffiths AJF, Gelbart WM, Miller JH, Lewontin RC. Les applications de la technologie de l’ADN recombinant. In: De Boeck Université editors. Analyse génétique moderne. Paris; 2001:341-412.
132. Bennett P. Demystified… microsatellites. Mol Pathol. 2000;53(4): 177-183.
133. Laird NM, Lange C. Family-based methods for linkage and association analysis. Adv Genet. 2008;60:219-252.
134. Rice JP, Saccone NL, Corbett J. Model-based methods for linkage analysis. Adv Genet. 2008;60:155-173.
135. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516-1517.
136. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437(7063):1299-1320.
137. Mocellin S, Rossi CR. Principles of gene microarray data analysis. Adv Exp Med Biol. 2007;593:19-30.
138. Denham S, Koppelman GH, Blakey J, et al. Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir Res. 2008; 9:38.
139. Rolph MS, Sisavanh M, Liu SM, Mackay CR. Clues to asthma pathogenesis from microarray expression studies. Pharmacol Ther. 2006;109(1-2):284-294.
140. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448(7152):470-473.
141. Verlaan DJ, Berlivet S, Hunninghake GM, et al. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet. 2009;85(3):377-393.
142. Rice TK, Schork NJ, Rao DC. Methods for handling multiple testing. Adv Genet. 2008;60:293-308.
143. Ziegler A, Konig IR, Thompson JR. Biostatistical aspects of genomewide association studies. Biom J. 2008;50(1):8-28.
144. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006;164(7):609-614.
145. Reimers M. Statistical analysis of microarray data. Addict Biol. 2005; 10(1):23-35.
146. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature. 2007;447(7145):655-660.
147. Guerra S, Martinez FD. Asthma genetics: from linear to multifactorial approaches. Annu Rev Med. 2008;59:327-341.
148. Martinez FD. Gene-environment interactions in asthma: with apologies to William of Ockham. Proc Am Thorac Soc. 2007;4(1):26-31.
149. Valdar W, Solberg LC, Gauguier D, et al. Genetic and environmental effects on complex traits in mice. Genetics. 2006;174(2): 959-984.
150. Eder W, Klimecki W, Yu L, et al. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. J Allergy Clin Immunol. 2005;116(3):601-607.
151. Simpson A, John SL, Jury F, et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med. 2006;174(4):386-392.
152. Zambelli-Weiner A, Ehrlich E, Stockton ML, et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol. 2005; 115(6):1203-1209.
153. Cameron L, Webster RB, Strempel JM, et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C.T, a polymorphism associated with allergic inflammation. J Immunol. 2006;177(12):8633-8642.
154. Krebs JE. Moving marks: dynamic histone modifications in yeast. Mol Biosyst. 2007;3(9):590-597.
155. Nightingale KP, O’Neill LP, Turner BM. Histone modifications: signaling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 2006;16(2):125-136.
156. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23(15):5293-5300.
157. Alati R, Al Mamun A, O’Callaghan M, Najman JM, Williams GM. In utero and postnatal maternal smoking and asthma in adolescence. Epidemiology. 2006;17(2):138-144.
158. Li YF, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest. 2005;127(4):1232-1241.
159. Magnusson LL, Olesen AB, Wennborg H, Olsen J. Wheezing, asthma, hayfever, and atopic eczema in childhood following exposure to tobacco smoke in fetal life. Clin Exp Allergy. 2005;35(12): 1550-1556.
160. Kabesch M, Schedel M, Carr D, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol. 2006;117(2):269-274.